Can I cut and paste this next week for NVDA?So buy half now, and buy half if they miss.
"If it goes up, let the shares run."
GBA PRESENTS- the public games
- Thread starter stonedinvestor
- Start date
"If it goes up, let the shares run."
So buy half now, and buy half if they miss.
Yes I bought only 75 shares but was willing to double down if theY missed because of some TA points.
I got the HF to make a larger wager on the name. But that's in their account.
HEY GIVE A GUY SOME LOVE--> 11-11 IN EARNINGS SEASON PRETTY DAMN GOOD!
THIS TRIAL IS IMPORTANT FOR MANKIND-:
How it works
Cancer has an invisibility cloak, hiding from the immune system. But the vaccine flags key components of the tumour as a threat, hopefully triggering the body to respond by obliterating cancer cells wherever they are.
Early trials on similar vaccines in other cancers have proved promising, with a reduction in tumour size and risk of recurrence.
This is the first time the BioNTech jab has been tested in humans. The trial will confirm whether there are any major side effects before doctors proceed to larger studies to establish clinical effectiveness.
Volunteers will receive dozens of doses over 12 months to keep boosting their immune system.
Dr Sarah Benafif, who is running the clinical trial at UCLH, has high hopes.
"We already have some data that this is quite a well-tolerated type of vaccine," she said.
"We hope in time we are able to show that the treatment is effective against lung cancer whilst leaving other tissues untouched."
How it works
Cancer has an invisibility cloak, hiding from the immune system. But the vaccine flags key components of the tumour as a threat, hopefully triggering the body to respond by obliterating cancer cells wherever they are.
Early trials on similar vaccines in other cancers have proved promising, with a reduction in tumour size and risk of recurrence.
This is the first time the BioNTech jab has been tested in humans. The trial will confirm whether there are any major side effects before doctors proceed to larger studies to establish clinical effectiveness.
Volunteers will receive dozens of doses over 12 months to keep boosting their immune system.
Dr Sarah Benafif, who is running the clinical trial at UCLH, has high hopes.
"We already have some data that this is quite a well-tolerated type of vaccine," she said.
"We hope in time we are able to show that the treatment is effective against lung cancer whilst leaving other tissues untouched."
I think they could beat but am not sure.--
There has been some bad mojo:
Workday faces increased competition, deal delays: Cleveland Research
But there are two sides of every coin.:
Workday earnings report may be better than feared, says Citi » 07:40 WDAY
Workday upgraded to Positive from Mixed view at OTR Global » 07:25 WDAY
Overall sentiment though remains very poor which means if they hit earn and guide up this will be an outsized move-:
-Workday price target lowered by $10 at Evercore ISI, » 08:11 WDAY
-Workday price target lowered by $15 at Wells Fargo, » 08/14 WDAY
<<<<<<<<<<<<<<<<<<< >>>>>>>>>>>>>>>>>>>>>>
Prob best way to play this is 1/2 now and 1/2 if they miss. If you are right just let the shares run.
RUN BABY RUN!!!!!!!!!!!!!!!
What are the dangers today?
Powell at 10:00 speaks. He just wants to see more data?<-- That's won't go over well. Result down market.
Powell places Sept firmly in play<--- Market will like that initially but I think still reverse.
I expect to be on a razors edge when NVDA's earn finally roll around...
Powell at 10:00 speaks. He just wants to see more data?<-- That's won't go over well. Result down market.
Powell places Sept firmly in play<--- Market will like that initially but I think still reverse.
I expect to be on a razors edge when NVDA's earn finally roll around...
Have you noticed my Sentinel 1 is getting upgraded every day.. why?
Buyout>?
SentinelOne price target raised by $5 at BTIG, » 07:04 S
Buyout>?
SentinelOne price target raised by $5 at BTIG, » 07:04 S
I view SNOW in a similar light to WDAY. These are popular HF names that are in danger of not being relevant unless they move now.
I would give to the edge to WDAY but I think we should think about SNOW here as well.
We are getting a 2nd bite at the apple as we upgraded before and the name had a great run we missed out on buying. Now back down again... SNOW is worth a look at least.
I would give to the edge to WDAY but I think we should think about SNOW here as well.
We are getting a 2nd bite at the apple as we upgraded before and the name had a great run we missed out on buying. Now back down again... SNOW is worth a look at least.
Normally I do not use firm stops but in this case I will @$113.00.
Big Pete likes to use stops more than me. He'll be happy.
Big Pete likes to use stops more than me. He'll be happy.
Congratulations carrier 52 week high club-~ 
CARR Carrier Global Corporation
$69.58
CARR Carrier Global Corporation
$69.58